| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/27/2007 | CN1986794A Light and heavy chain variable region gene of monoclonal antibody for resisting protective anthrax bacillus antigen and its application |
| 06/27/2007 | CN1322899C Anti cancer gene medicinal composition, micromolecule interfere RNA and its filtrate method |
| 06/27/2007 | CN1322898C Small interference RNA molecule SiRNA capable of attacking human hepatitis B virus and application thereof |
| 06/27/2007 | CN1322897C Use of IL-18 inhibitors |
| 06/26/2007 | US7235650 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis |
| 06/26/2007 | US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
| 06/26/2007 | US7235534 Oligonucleotide or polynucleotide for treating vascular healing after surgery, preventing atherosclerotic plaque, vein graft healing, cardiovascular disorders |
| 06/26/2007 | US7235393 Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues |
| 06/26/2007 | US7235391 Bulking agents, cryoprotectants and lyoprotectants added for storage stability |
| 06/26/2007 | US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 06/26/2007 | US7235371 Human osteoclast derived cathepsin |
| 06/26/2007 | US7235244 Compositions and methods for treating papillomavirus-infected cells |
| 06/26/2007 | US7235236 A replication-defective adenoviral or adeno-associated viral vector; gene therapy for congestive heart failure |
| 06/26/2007 | US7235235 Alphavirus RNA replicon systems |
| 06/26/2007 | US7235233 Fiber protein of seretype 11, 16, 35, 40 and/or 51; efficient transduction; nucleic acid transfer |
| 06/26/2007 | CA2265464C Therapy for .alpha.-galactosidase a deficiency |
| 06/26/2007 | CA2186423C Protein which induces interferon-gamma production by immunocompetent cell |
| 06/26/2007 | CA2154445C Lysosomal targeting of immunogens |
| 06/26/2007 | CA2065797C Monoclonal antibody, polypeptide and production thereof |
| 06/21/2007 | WO2007070856A2 Method for treating immune dysfunction by regulation of cd40 ligand expression |
| 06/21/2007 | WO2007070705A2 Cationic lipid-mediated vectors |
| 06/21/2007 | WO2007070501A2 A vaccination method |
| 06/21/2007 | WO2007070483A2 Micrornas that regulate muscle cell proliferation and differentiation |
| 06/21/2007 | WO2007070430A2 Identification and application of antibiotic synergy |
| 06/21/2007 | WO2007070175A2 Natriuretic peptide related fragment in cardiovascular disease |
| 06/21/2007 | WO2007069795A1 Method for prevention of tumor |
| 06/21/2007 | WO2007069247A2 Polynucleotides and polypeptide of human kv1.3, compositions comprising same and methods of using same |
| 06/21/2007 | WO2007068803A1 Novel neurotrophic factor protein and uses thereof |
| 06/21/2007 | WO2007068772A1 Novel conditionally-replicating recombinant adenoviruses (crad) |
| 06/21/2007 | WO2007068478A1 Rna helicase as marker for rare tumours |
| 06/21/2007 | WO2007068115A1 Method of detecting and reducing boar taint using nuclear receptors |
| 06/21/2007 | WO2007068113A1 4'-thioarabinonucleotide-containing oligonucleotides, compounds and methods for their preparation and uses thereof |
| 06/21/2007 | WO2007068112A1 Method of treating pain by using opioids and camkiv inhibitors |
| 06/21/2007 | WO2006081216A3 Method and system for communicating between an embedded device and relational databases |
| 06/21/2007 | WO2006010041A3 Morpholino antisense drugs for human herpesvirus 8 |
| 06/21/2007 | US20070143871 Non-human transgenic animal models for hepatocellular carcinoma |
| 06/21/2007 | US20070142316 Antisense IAP oligonucleotides and uses thereof |
| 06/21/2007 | US20070142315 stimulate Toll-like receptor 8 (TLR8); drug delivery; cancer, an allergic condition, asthma, airway remodeling, or immunodeficiency |
| 06/21/2007 | US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture |
| 06/21/2007 | US20070142313 MicroRNA1 therapies |
| 06/21/2007 | US20070142312 Antigen delivery system |
| 06/21/2007 | US20070142288 Isolated MCPIP and methods of use |
| 06/21/2007 | US20070142277 Bace455, an alternative splice variant of the human beta-secretase |
| 06/21/2007 | US20070141708 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 06/21/2007 | US20070141677 Genetic immunization with cationic lipids |
| 06/21/2007 | US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 06/21/2007 | US20070141611 siRNA targeting spleen tyrosine kinase |
| 06/21/2007 | US20070141590 Modulators of tissue regeneration |
| 06/21/2007 | US20070141579 MUM-1 protein expressed by multiple myeloma-related gene |
| 06/21/2007 | US20070141134 Shielded micelles for polynucleotide delivery |
| 06/21/2007 | US20070141128 Wound cleansing apparatus with actives |
| 06/21/2007 | US20070141111 Porous medical device and method for its manufacture |
| 06/21/2007 | US20070141080 Treating severe acute respiratory syndrome |
| 06/21/2007 | US20070141068 Methods for the treatment of carcinoma |
| 06/21/2007 | US20070141067 Targeted cancer therapy |
| 06/21/2007 | US20070141047 Feline immunoglobulin e proteins and compositions thereof |
| 06/21/2007 | US20070141038 Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target site |
| 06/21/2007 | US20070141030 Targeted pre-mRNA/mRNA modification and gene regulation |
| 06/21/2007 | US20070141029 Methods of gene therapy for treating disorders of the ear by adminstering a vector encoding an antonal-associated factor |
| 06/21/2007 | US20070141028 Cancer gene therapeutic drug |
| 06/21/2007 | US20070141027 Non-lethal conditioning methods for conditioning a recipient for bone marrow transplantation |
| 06/21/2007 | US20070141020 Use of biocompatible polymers for the preparation of a composition or a medical device |
| 06/21/2007 | US20070141009 Sirna mediated post-transriptional gene silencing of genes involved in alopecia |
| 06/21/2007 | CA2634046A1 Micrornas that regulate muscle cell proliferation and differentiation |
| 06/21/2007 | CA2633296A1 Method of detecting and reducing boar taint using nuclear receptors |
| 06/21/2007 | CA2632451A1 Cell penetrating peptides for intracellular delivery of molecules |
| 06/21/2007 | CA2627176A1 Polynucleotides and polypeptide of human kv1.3, compositions comprising same and methods of using same |
| 06/20/2007 | EP1798287A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798286A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798285A1 Methods and medicament for inhibition the expression of a defined gene |
| 06/20/2007 | EP1797898A1 Preventive/therapeutic drug for arteriosclerosis |
| 06/20/2007 | EP1797897A1 Medicinal composition containing meltrin antagonist |
| 06/20/2007 | EP1797183A2 Regulation of oncogenes by micrornas |
| 06/20/2007 | EP1796732A2 Modified small interfering rna molecules and methods of use |
| 06/20/2007 | EP1796472A2 Modulation of bio-electrical rhythms via a novel engineering approach |
| 06/20/2007 | EP1567653B1 Recombinant poxvirus comprising at least two cowpox ati promoters |
| 06/20/2007 | EP1485410B1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |
| 06/20/2007 | EP1358353B1 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 06/20/2007 | EP1105408B1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/20/2007 | EP0789593B1 Yeast-based delivery vehicles |
| 06/20/2007 | EP0745121B1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 06/20/2007 | CN1985002A GM3 synthase as a therapeutic target in microvascular complications of diabetes |
| 06/20/2007 | CN1984996A Replication competent viruses capable of silencing virus inhibitory factor expression |
| 06/20/2007 | CN1984921A Modulation of survivin expression |
| 06/20/2007 | CN1982455A Polynucleotide for inhibiting Wnt activity, its encoded polypeptide and use |
| 06/20/2007 | CN1982454A Related gene of osteoporosis, its encoded protein and use |
| 06/20/2007 | CN1982453A Use of human gene and its encoded polypeptide |
| 06/20/2007 | CN1982324A Oncogene, recombinant protein derived therefrom, and uses thereof |
| 06/20/2007 | CN1981887A Therapeutic use of growth factor, and delivery device, especially for the treatment of intima hyperplasia |
| 06/20/2007 | CN1981873A Method of manufacturing micro colloidal particle and use of the same |
| 06/20/2007 | CN1981872A Use of PUMA in tumor chemoradiotherapy sensibilization |
| 06/20/2007 | CN1322137C Equine infections anaemia virus (EIAV) based |
| 06/20/2007 | CN1322135C Configuration of cell facter IL-24 eucargon expression carrier and application |
| 06/20/2007 | CN1322127C BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 06/20/2007 | CN1322016C Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 06/20/2007 | CN1321689C Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/19/2007 | US7232899 Targeted plasmids comprising viral tripartite leader (TPL) sequences for facilitating development of high capacity gene therapy/transfer tools |
| 06/19/2007 | US7232806 Small temporal RNA rannging from 21 and 22 base pairs for use regulatory modulators of gene expression; treatment and prevention of cell proliferative disorders |
| 06/19/2007 | US7232683 Extracellular matrix signaling molecules |